Overview
-

Innovacell Inc.

Innovacell Co., Ltd. is a Japanese clinical-stage biopharmaceutical company focused on the research, development, and commercialization of autologous cell therapy products (regenerative medicine products) targeting incontinence disorders, specifically fecal and urinary incontinence. The company operates three pipelines—ICEF15 (urge fecal incontinence), ICEF16 (passive fecal incontinence), and ICES13 (stress urinary incontinence)—based on proprietary skeletal muscle-derived myoblast technology developed by its wholly owned Austrian subsidiary, Innovacell GmbH. Its most advanced pipeline, ICEF15, is currently in an international Phase III clinical trial spanning Japan and Europe, with U.S. site additions underway, and the company employs a 'Global Aggregation Model' to source, develop, and commercialize promising cell therapy assets worldwide.

Market Cap
¥21.1B
US$135M
EV
¥12.9B
US$82.2M
Stock¥468▼-4.10%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
NM
LTM EV/EBIT
NM
LTM PER
NM
LTM PBR
2.2
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-59.4%pt
100
Feb 24, 26 – Oct 23, 26StockTOPIX
MC → EV Bridge
21.1BUS$135MMarket Cap2.70BUS$17.2M+ Debt10.9BUS$69.6M− Cash0.00BUS$0.00M− Inv. Sec.12.9BUS$82.2MEV
AI Briefing
Generating insights…
Performance & Balance
Net Income 5Y (¥B)
-2.00-US$12.8M'23/12-2.39-US$15.3M'24/12-2.86-US$18.2M'25/12
Capital Structure
78%
22%
EquityD/E 0.28xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
'23/121.96US$12.5M4.16US$26.5M'24/124.10US$26.2M5.72US$36.5M'25/12
Shareholders
Top 10 hold 53.4%
1
PEPPERMINT GROVE LIMITED
7.99%
2
INSANNA Stiftung
7.99%
3
Seeds Investment LLP
5.45%
4
THE PRUDENTIAL ASSURANCE COMPANY LIMITED
5.21%
5
Jason SEEGER
5.12%
6
Colin NOVIC
5.12%
7
Custody Bank of Japan, Ltd. (Trust Account)
5.02%
8
MARKSTEINER RAINER HUBERT
4.74%
9
Atsushi SAKANO
3.64%
10
Alfresa Corporation
3.09%
Management
8 officers
Colin NOVIC
Representative Director, Co-CEO
Apr 2007 Joined Tohmatsu Consulting Co., Ltd. (now Deloitte Tohmatsu Consulting LLC) Aug 2010 Joined Nikko Cordial Securities Inc. (now SMBC Nikko Securities Inc.) Nov 2012 Representative Director, CJ PARTNERS Co., Ltd. Oct 2016 Representative Director, REGENEUS JAPAN K.K. Dec 2016 Director, CMAX Clinical Research Pty Ltd. Aug 2020 Director, DiscGenics, Inc. (current) Jul 2021 Director, the Company Mar 2022 Representative Director, CEO, the Company Jul 2023 Director, Innovacell GmbH (current) Mar 2025 Representative Director, Co-CEO, the Company (current)
1981-04-03
Jason SEEGER
Representative Director, Co-CEO
Oct 2007 Joined Tohmatsu Consulting Co., Ltd. (now Deloitte Tohmatsu Consulting LLC) Nov 2011 Joined SMBC Nikko Securities Inc. Nov 2012 Representative Director, CJ PARTNERS Co., Ltd. Jan 2021 Representative Director, the Company Apr 2021 Representative Director, COO, the Company Jul 2023 Director, Innovacell GmbH (current) Mar 2025 Representative Director, Co-CEO, the Company (current)
1982-08-15
Rainer MARKSSTEINER
Director, CSO
Jan 1999 Postdoctoral Researcher, Department of Pharmacology and Biochemistry, University of Innsbruck Jan 2002 Joined Innovacell Biotechnologie GmbH (now Innovacell GmbH) Jan 2005 Director, Innovacell Biotechnologie GmbH (now Innovacell GmbH) Aug 2008 Director, Innovacell Biotechnologie AG (now Innovacell GmbH) Feb 2021 Director, Innovacell AG (now Innovacell GmbH) (current) Apr 2021 Director, CSO, the Company (current)
1969-09-09
Yasufumi HOSONO
Director, CFO
Apr 1989 Joined The Mitsui Bank, Limited (now Sumitomo Mitsui Banking Corporation) Sep 1999 Joined Bain & Company Japan, Inc. Aug 2006 Director, CFO, Cellseed Inc. Feb 2015 Executive Officer, CFO, SBI Mortgage Co., Ltd. (now SBI ARUHI Corporation) May 2015 Director, CSO, Aruhi Corporation (now SBI ARUHI Corporation) Jun 2015 Director, Aruhi Lease Co., Ltd. (now Mitsui Sumitomo Trust Panasonic Finance Co., Ltd.) Jul 2015 Executive Officer, CFO, Aruhi Group Co., Ltd. (now SBI ARUHI Corporation) Jun 2016 Managing Director, CFO, Aruhi Corporation (now SBI ARUHI Corporation) Mar 2017 Director, CFO, Aruhi Group Co., Ltd. (now SBI ARUHI Corporation) Jun 2017 Managing Director, CFO, Aruhi Group Co., Ltd. (now SBI ARUHI Corporation) Aug 2017 Managing Director, CSO, Aruhi Group Co., Ltd. (now SBI ARUHI Corporation) Jun 2019 Managing Director, Forum Engineering, Inc. Jul 2021 Director, CFO, the Company (current) Jul 2023 Director, Innovacell GmbH (current)
1966-12-10
Arata MATSUZAWA
Director
Mar 2002 Joined Diabetes Center, Tokyo Women's Medical University Apr 2005 Joined Department of Dermatology, Tokyo Women's Medical University Apr 2008 Joined Kasumigaseki Urban Clinic Apr 2012 Joined Omotesando Skin Clinic (current) Jun 2014 Representative Director, Mediskin Inc. (current) Apr 2017 Part-time Lecturer, Faculty of Medicine, University of the Ryukyus Dec 2017 Director, Medical Corporation Yu-no-kai (current) Apr 2020 Shirono Clinic (current) Apr 2022 Visiting Professor, Baika Women's University (current) Apr 2024 Visiting Professor, Faculty of Pharmaceutical Sciences, Tokyo University of Pharmacy and Life Sciences (current) Oct 2025 Outside Director, the Company (current)
1978-03-30
Shigeru TAKAGI
Full-time Statutory Auditor
Nov 1982 Joined Sony Corporation Feb 1983 Joined Sony Magnescale Inc. Nov 1986 Joined Sony Chemicals Corporation Apr 1992 Joined Sony Precision Technology America Inc.; concurrently CFO, Sony Transcom Co. Jul 1995 Joined Sony Hong Kong Ltd. Oct 1996 Joined Kadokawa Shoten Publishing Co., Ltd. Apr 2004 Joined Kadokawa Holdings, Inc. (now KADOKAWA Corporation); Director, Kadokawa Entertainment Inc. (now KADOKAWA Corporation) Jun 2006 Director, Kadokawa Holdings, Inc. (now KADOKAWA Corporation) Jul 2008 Managing Director, Kadokawa Entertainment Inc. (now KADOKAWA Corporation) Jul 2009 Managing Director, Kadokawa Pictures Inc. (now KADOKAWA Corporation) Jul 2010 Representative Director, Disk Road Inc. Jun 2013 Advisor, Lintec 21 Corporation Jul 2014 Representative Director, Arbiz Co., Ltd. (dormant) (current) May 2016 Full-time Statutory Auditor, EMTG Inc. (now M-up Inc.) Jun 2018 Outside Director, Ekitan Inc. Sep 2019 Executive Officer, Shin Corporation Mar 2020 Senior Fellow, Venture Business Laboratory, Chiba University Jul 2021 Full-time Statutory Auditor, the Company (current)
1958-09-22
Keiichi KAMISUMI
Outside Statutory Auditor
Oct 1992 Joined Chuo Coopers & Lybrand International Tax Office (now PwC Tax Japan) Jan 1997 Joined PricewaterhouseCoopers (LA) Jan 2000 Joined Rojam Entertainment Holdings Limited (Hong Kong) Jul 2004 Established Biz Advisors Inc.; Representative Director (current) Sep 2005 Outside Statutory Auditor, Golf Digest Online Inc. Oct 2007 Outside Statutory Auditor, Golf Paradise Co., Ltd. Oct 2022 Outside Statutory Auditor, the Company (current)
1969-10-06
Mariko HIROSE
Outside Statutory Auditor
Apr 1995 Registered as attorney (Daini Tokyo Bar Association) Apr 1995 Joined Brown Moriya Hoashi & Kubota Law Office Jul 1997 Joined Haruki Sawai Inoue Law Office (now Tokyo Marunouchi Law Office) Feb 2000 Joined Mitsui Yasuda Law Office Oct 2004 Joined Nishimura & Asahi Oct 2009 Established Sunflower Law Office Mar 2017 Outside Statutory Auditor, Cellseed Inc. Jun 2018 Outside Statutory Auditor, Digital Media Professionals Inc. (current) Mar 2021 Outside Director (Audit and Supervisory Committee Member), Cellseed Inc. Oct 2022 Outside Statutory Auditor, the Company (current)
1967-09-21
Large Shareholding Reports
Novic Corin
2026-06-08
5.49%→5.41%
Annual report (as of 2026-06-30): 5.12%
M&G Investments (Singapore) Pte. Ltd.
2026-03-06
8.99%
Chikanori JONO
2026-03-03
6.11%
Jason SEEGER
2026-03-02
5.49%
Annual report (as of 2026-06-30): 5.12%
Rainer Marksteiner
2026-03-02
5.25%
Novic Corin
2026-03-02
5.49%
Annual report (as of 2026-06-30): 5.12%
INSANNA Stiftung
2026-03-02
8.18%
Annual report (as of 2026-06-30): 7.99%
Peppermint Grove Limited Director Toyotaka Mori
2026-02-26
9.45%→8.19%
Peppermint Grove Limited
2026-02-25
9.45%→8.19%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-08-06
Semi-Annual Securities Report
Period: Jan 2026 – Dec 2026
EDINET
2026-06-08
Large Shareholding Report
TDnet
2026-05-13
Q1 Earnings Flash
FY ending Dec 2026
EDINET
2026-03-26
Annual Securities Report
Period: Jan 2025 – Dec 2025
EDINET
2026-03-06
Large Shareholding Report
EDINET
2026-03-03
Large Shareholding Report
EDINET
2026-03-02
Large Shareholding Report
EDINET
2026-03-02
Large Shareholding Report
EDINET
2026-03-02
Large Shareholding Report
EDINET
2026-03-02
Large Shareholding Report
EDINETAmended
2026-02-26
Change Report
EDINET
2026-02-25
Large Shareholding Report
EDINETAmended
2026-02-12
Amended Securities Registration Statement
EDINETAmended
2026-02-04
Amended Securities Registration Statement
EDINET
2026-01-19
Securities Registration Statement
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →